Consolidated Appropriations Act, 2026

This bill provides full FY2026 appropriations for five major federal departments, ensuring continued operations and contract disbursements for the remainder of the fiscal year. This eliminates uncertainty for defense contractors, healthcare providers, financial institutions, and transportation/housing companies that rely on federal spending. The immediate clarity allows these companies to plan and execute existing contracts without interruption. The Department of Homeland Security (DHS) is explicitly excluded from full FY2026 funding, receiving only a short-term continuing resolution through February 13, 2026. This creates a period of uncertainty for DHS contractors, as their full FY2026 budgets are not yet finalized. The funding mechanism is direct appropriation, meaning federal departments receive specific budgets to disburse through contracts, grants, and operational spending. Defense contractors like Lockheed Martin ($LMT), Raytheon Technologies ($RTX), General Dynamics ($GD), and Boeing ($BA) are positioned to continue receiving payments for ongoing programs and new orders. Healthcare providers, including large managed care organizations like UnitedHealth Group ($UNH) and pharmacy benefit managers like CVS Health ($CVS), will see continued federal payments for Medicare/Medicaid services. Financial institutions such as JPMorgan Chase ($JPM), Bank of America ($BAC), and Wells Fargo ($WFC) benefit from stable government operations and continued financial services contracts. Transportation companies like CSX Corporation ($CSX), Union Pacific Corporation ($UNP), FedEx Corporation ($FDX), and UPS ($UPS) will see consistent demand from federal logistics and infrastructure projects. Historically, omnibus spending bills or consolidated appropriations acts that fully fund major departments remove significant market uncertainty. For example, when the Consolidated Appropriations Act, 2023, passed in December 2022, defense stocks like $LMT and $RTX saw stable performance, with $LMT gaining 2% in the subsequent month as contract visibility improved. Healthcare stocks like $UNH also maintained upward momentum, gaining 3% in the same period. Conversely, sectors facing continuing resolutions often experience short-term volatility. The lack of full funding for DHS creates a temporary overhang for companies heavily reliant on DHS contracts, such as certain cybersecurity firms or border security technology providers, until February 13, 2026. Specific winners include Lockheed Martin ($LMT), Raytheon Technologies ($RTX), General Dynamics ($GD), and Boeing ($BA) due to full defense funding. UnitedHealth Group ($UNH) and CVS Health ($CVS) benefit from stable healthcare appropriations. JPMorgan Chase ($JPM), Bank of America ($BAC), and Wells Fargo ($WFC) gain from consistent financial services operations. CSX Corporation ($CSX), Union Pacific Corporation ($UNP), FedEx Corporation ($FDX), and UPS ($UPS) will see stable demand from transportation and infrastructure spending. There are no immediate specific losers identified by ticker, but companies with significant exposure to DHS contracts face temporary uncertainty until February 13, 2026. This bill ensures the continued flow of federal funds to these established contractors. What happens next is that the funded departments will continue their operations and contract disbursements as planned for the remainder of FY2026. For DHS, the continuing resolution means Congress must pass further legislation by February 13, 2026, to avoid a partial shutdown or to provide full FY2026 funding. This creates a future legislative event that will impact DHS-dependent contractors.